3-(3-吡啶基)-2-膦酰基丙酸的N-氧化物衍生物作为Rab香叶基香叶基化的潜在抑制剂
N-Oxide derivatives of 3-(3-pyridyl)-2-phosphonopropanoic acids as potential inhibitors of Rab geranylgeranylation.
作者信息
Zhou Xiang, Born Ella J, Allen Cheryl, Holstein Sarah A, Wiemer David F
机构信息
Department of Chemistry, University of Iowa, Iowa City, IA 52242-1294, USA.
Department of Internal Medicine, University of Iowa, Iowa City, IA 52242-1294, USA.
出版信息
Bioorg Med Chem Lett. 2015 Jun 1;25(11):2331-4. doi: 10.1016/j.bmcl.2015.04.021. Epub 2015 Apr 17.
Abstract
The N-oxide derivatives of [2-(3-pyridinyl)-1-hydroxyethylidene-1,1-phosphonocarboxylic acid (or PEHPC) and [2-(3-pyridinyl)-1-ethylidene-1,1-phosphonocarboxylic acid (or PEPC) have been prepared and evaluated for their activity against several enzymes which utilize isoprenoids. The parent pyridines are known inhibitors of GGTase II, but the N-oxide derivatives show no improvement in biological activity in assays with the isolated enzyme. However, the PEHPC N-oxide did induce significant accumulation of intracellular light chain in myeloma cells, consistent with inhibition of Rab geranylgeranylation.
摘要
已制备了[2-(3-吡啶基)-1-羟基亚乙基-1,1-膦酰基羧酸（或PEHPC）和[2-(3-吡啶基)-1-亚乙基-1,1-膦酰基羧酸（或PEPC）的N-氧化物衍生物，并对它们针对几种利用类异戊二烯的酶的活性进行了评估。母体吡啶是已知的γ-谷氨酰转移酶II抑制剂，但在与分离酶的测定中，N-氧化物衍生物的生物活性没有改善。然而，PEHPC N-氧化物确实在骨髓瘤细胞中诱导了细胞内轻链的显著积累，这与Rab香叶基香叶基化的抑制一致。
相似文献
1
N-Oxide derivatives of 3-(3-pyridyl)-2-phosphonopropanoic acids as potential inhibitors of Rab geranylgeranylation.3-(3-吡啶基)-2-膦酰基丙酸的N-氧化物衍生物作为Rab香叶基香叶基化的潜在抑制剂
Bioorg Med Chem Lett. 2015 Jun 1;25(11):2331-4. doi: 10.1016/j.bmcl.2015.04.021. Epub 2015 Apr 17.
2
Selective inhibition of Rab prenylation by a phosphonocarboxylate analogue of risedronate induces apoptosis, but not S-phase arrest, in human myeloma cells.利塞膦酸盐的膦酰基羧酸类似物对Rab异戊二烯化的选择性抑制可诱导人骨髓瘤细胞凋亡，但不会导致S期阻滞。
Int J Cancer. 2006 Sep 15;119(6):1254-61. doi: 10.1002/ijc.21977.
3
Phosphonocarboxylate inhibitors of Rab geranylgeranyl transferase disrupt the prenylation and membrane localization of Rab proteins in osteoclasts in vitro and in vivo.Rab 香叶基香叶基转移酶的膦酰基羧酸盐抑制剂在体外和体内破坏破骨细胞中 Rab 蛋白的异戊二烯化和膜定位。
Bone. 2005 Sep;37(3):349-58. doi: 10.1016/j.bone.2005.04.021.
4
Synthesis and Biological Evaluation of Imidazole-Bearing α-Phosphonocarboxylates as Inhibitors of Rab Geranylgeranyl Transferase (RGGT).咪唑基-α-膦酸羧酸盐的合成与生物评价作为 Rab 香叶基香叶基转移酶 (RGGT) 的抑制剂。
ChemMedChem. 2018 Apr 23;13(8):842-851. doi: 10.1002/cmdc.201700791. Epub 2018 Mar 2.
5
Synthesis, chiral high performance liquid chromatographic resolution and enantiospecific activity of a potent new geranylgeranyl transferase inhibitor, 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic acid.合成、手性高效液相色谱拆分及一种新型强效法尼基转移酶抑制剂 2-羟基-3-咪唑并[1,2-a]吡啶-3-基-2-膦酸丙酸的对映体活性。
J Med Chem. 2010 May 13;53(9):3454-64. doi: 10.1021/jm900232u.
6
Development of selective, potent RabGGTase inhibitors.开发选择性、强效的 RabGGTase 抑制剂。
J Med Chem. 2012 Oct 11;55(19):8330-40. doi: 10.1021/jm300624s. Epub 2012 Oct 3.
7
Triazole-based inhibitors of geranylgeranyltransferase II.三氮唑基香叶基香叶基转移酶 II 抑制剂。
Bioorg Med Chem Lett. 2013 Feb 1;23(3):764-6. doi: 10.1016/j.bmcl.2012.11.089. Epub 2012 Dec 1.
8
Characterization of the in vitro activity of AZD3409, a novel prenyl transferase inhibitor.AZD3409，一种新型的法尼基转移酶抑制剂的体外活性特征。
Cancer Chemother Pharmacol. 2011 Jan;67(1):137-45. doi: 10.1007/s00280-010-1300-6. Epub 2010 Mar 13.
9
Design, synthesis, and characterization of peptide-based rab geranylgeranyl transferase inhibitors.基于肽的 rab 异戊二烯基转移酶抑制剂的设计、合成与表征。
J Med Chem. 2009 Dec 24;52(24):8025-37. doi: 10.1021/jm901117d.
10
Inhibition of geranylgeranylation mediates sensitivity to CHOP-induced cell death of DLBCL cell lines.抑制法呢基焦磷酸化介导 CHOP 诱导的弥漫性大 B 细胞淋巴瘤细胞系细胞死亡的敏感性。
Exp Cell Res. 2011 May 1;317(8):1179-91. doi: 10.1016/j.yexcr.2011.02.006. Epub 2011 Feb 13.
引用本文的文献
1
Targeting the Isoprenoid Biosynthetic Pathway in Multiple Myeloma.靶向多发性骨髓瘤的异戊烯生物合成途径。
Int J Mol Sci. 2022 Dec 21;24(1):111. doi: 10.3390/ijms24010111.
2
Targeting prenylation inhibition through the mevalonate pathway.通过甲羟戊酸途径靶向异戊二烯化抑制作用。
RSC Med Chem. 2019 Dec 23;11(1):51-71. doi: 10.1039/c9md00442d. eCollection 2020 Jan 1.
3
Novel benzimidazole phosphonates as potential inhibitors of protein prenylation.新型苯并咪唑膦酸酯作为蛋白质异戊烯化的潜在抑制剂。
Bioorg Med Chem Lett. 2019 Dec 15;29(24):126757. doi: 10.1016/j.bmcl.2019.126757. Epub 2019 Oct 31.
4
P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.由p53和甲羟戊酸途径驱动的恶性肿瘤转移和耐药需要Arf6。
J Cell Biol. 2016 Apr 11;213(1):81-95. doi: 10.1083/jcb.201510002. Epub 2016 Apr 4.
本文引用的文献
1
Updates on mechanism of action and clinical efficacy of risedronate in osteoporosis.利塞膦酸盐治疗骨质疏松症的作用机制及临床疗效研究进展
Clin Cases Miner Bone Metab. 2014 Sep;11(3):208-14.
2
Geranyl and neryl triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase.香叶基和橙花基三唑双膦酸盐作为香叶基香叶基二磷酸合酶的抑制剂
Bioorg Med Chem. 2014 May 1;22(9):2791-8. doi: 10.1016/j.bmc.2014.03.014. Epub 2014 Mar 24.
3
Targeting HSP90 and monoclonal protein trafficking modulates the unfolded protein response, chaperone regulation and apoptosis in myeloma cells.靶向 HSP90 和单克隆蛋白转运可调节骨髓瘤细胞中的未折叠蛋白反应、伴侣调节和细胞凋亡。
Blood Cancer J. 2013 Dec 6;3(12):e167. doi: 10.1038/bcj.2013.64.
4
Triazole-based inhibitors of geranylgeranyltransferase II.三氮唑基香叶基香叶基转移酶 II 抑制剂。
Bioorg Med Chem Lett. 2013 Feb 1;23(3):764-6. doi: 10.1016/j.bmcl.2012.11.089. Epub 2012 Dec 1.
5
Development of selective, potent RabGGTase inhibitors.开发选择性、强效的 RabGGTase 抑制剂。
J Med Chem. 2012 Oct 11;55(19):8330-40. doi: 10.1021/jm300624s. Epub 2012 Oct 3.
6
Psoromic acid is a selective and covalent Rab-prenylation inhibitor targeting autoinhibited RabGGTase.角鲨胺是一种选择性和共价的 Rab prenylation 抑制剂，针对自抑制的 RabGGTase。
J Am Chem Soc. 2012 May 2;134(17):7384-91. doi: 10.1021/ja211305j. Epub 2012 Apr 22.
7
Structure-guided development of selective RabGGTase inhibitors.
Angew Chem Int Ed Engl. 2011 May 16;50(21):4957-61. doi: 10.1002/anie.201101210. Epub 2011 Apr 21.
8
The relationship between the chemistry and biological activity of the bisphosphonates.双膦酸盐的化学和生物学活性之间的关系。
Bone. 2011 Jul;49(1):20-33. doi: 10.1016/j.bone.2011.03.774. Epub 2011 Apr 9.
9
Synthesis and biological evaluation of a series of aromatic bisphosphonates.一系列芳香族双膦酸盐的合成及生物评价。
Bioorg Med Chem. 2010 Oct 15;18(20):7212-20. doi: 10.1016/j.bmc.2010.08.036. Epub 2010 Aug 19.
10
Isoprenoid biosynthetic pathway inhibition disrupts monoclonal protein secretion and induces the unfolded protein response pathway in multiple myeloma cells.异戊烯生物合成途径抑制可破坏多发性骨髓瘤细胞中单克隆蛋白的分泌，并诱导未折叠蛋白反应途径。
Leuk Res. 2011 Apr;35(4):551-9. doi: 10.1016/j.leukres.2010.08.008. Epub 2010 Sep 9.
Zotero 插件